Nuclear Localization of IRG1 Modulates COX2 Expression and Prostaglandin Biosynthesis in Primary Human Macrophages 2308479

Abstract Introduction Immunometabolism within macrophages represents a dynamic process modulated by environmental factors and pathological conditions. Immune Responsive Gene 1 (IRG1) catalyzes the conversion of cis-aconitate, an intermediate in the tricarboxylic acid (TCA) cycle, to itaconate, and is robustly upregulated in macrophages following toll-like receptor engagement or type II interferon stimulation. The upregulation of IRG1 results in reduced macrophage cytokine production and influences polarization. To date, IRG1 localization has primarily been associated with mitochondria. In this study, we present evidence that IRG1 is also present in the nucleus of macrophages, where it associates with several promoters, including one controlling expression of PTGS2 (COX2), the rate-limiting enzyme in prostaglandin synthesis. Methods In these studies, we employed a multi-omic strategy incorporating ChIP-seq, RNA-seq, global proteomics, and metabolomics. To establish the biological significance of this novel IRG1 function, we generated CRISPR knockouts in human monocyte-derived macrophages and utilized a DSS-induced colitis model to assess inflammation in vivo. Results Through a multi-omic approach encompassing ChIP-seq, RNA-seq, global differential proteomics, and metabolomics, we have elucidated a nuclear function for IRG1 in primary human macrophages influencing prostaglandin biosynthesis. Additionally, investigations using a CRISPR-generated catalytically inactive IRG1 point mutant in THP1 cells demonstrated significant binding of IRG1 to the PTGS2 promoter, resulting in increased COX2 transcript and protein expression independent of itaconate production. Conclusion Collectively, these results reveal a novel, nuclear role for IRG1 in macrophages that provides a deeper understanding of how IRG1 may regulate macrophage function in the context of inflammation. Funding Source Eli Lilly and Company Topic Categories Cellular Adhesion, Migration, and Inflammation (CAM)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2026-07-28
DOI
https://doi.org/10.1093/jimmun/vkag141.1439
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nuclear Localization of IRG1 Modulates COX2 Expression and Prostaglandin Biosynthesis in Primary Human Macrophages 2308479

Chunlao Tang, Ian Lamb, C A Dorsey, Linda Chung et al.
The Journal of Immunology
Immune cells in cancer
article

Nuclear Localization of IRG1 Modulates COX2 Expression and Prostaglandin Biosynthesis in Primary Human Macrophages 2308479

Chunlao Tang, Ian Lamb, C A Dorsey, Linda Chung, Cindy Wang, Junpeng Xiao, Katie Acken, Jaiya Randhawa, Robert Benschop, Abigail Pajulas, Luke Bourner, Andrew Grigdesby, Anthony Cannon, Luke O’Neill, Jordan Yokubonus, Anne Mc-GettrickDillon
article en

Abstract

Abstract Introduction Immunometabolism within macrophages represents a dynamic process modulated by environmental factors and pathological conditions. Immune Responsive Gene 1 (IRG1) catalyzes the conversion of cis-aconitate, an intermediate in the tricarboxylic acid (TCA) cycle, to itaconate, and is robustly upregulated in macrophages following toll-like receptor engagement or type II interferon stimulation. The upregulation of IRG1 results in reduced macrophage cytokine production and influences polarization. To date, IRG1 localization has primarily been associated with mitochondria. In this study, we present evidence that IRG1 is also present in the nucleus of macrophages, where it associates with several promoters, including one controlling expression of PTGS2 (COX2), the rate-limiting enzyme in prostaglandin synthesis. Methods In these studies, we employed a multi-omic strategy incorporating ChIP-seq, RNA-seq, global proteomics, and metabolomics. To establish the biological significance of this novel IRG1 function, we generated CRISPR knockouts in human monocyte-derived macrophages and utilized a DSS-induced colitis model to assess inflammation in vivo. Results Through a multi-omic approach encompassing ChIP-seq, RNA-seq, global differential proteomics, and metabolomics, we have elucidated a nuclear function for IRG1 in primary human macrophages influencing prostaglandin biosynthesis. Additionally, investigations using a CRISPR-generated catalytically inactive IRG1 point mutant in THP1 cells demonstrated significant binding of IRG1 to the PTGS2 promoter, resulting in increased COX2 transcript and protein expression independent of itaconate production. Conclusion Collectively, these results reveal a novel, nuclear role for IRG1 in macrophages that provides a deeper understanding of how IRG1 may regulate macrophage function in the context of inflammation. Funding Source Eli Lilly and Company Topic Categories Cellular Adhesion, Migration, and Inflammation (CAM)

The Journal of ImmunologyVol. 215(Supplement_1)
Eli Lilly (United States) (US), Watershed (GB)
Openalex Percentile: Top 15%
Immune cells in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.